ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,853Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 973

$639K Total Retail Price of All Prescriptions

Rank: 59 out of 973

581 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 581 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 581 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,933 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 567 493 1 3
SIMVASTATIN 505 478 2 1
LEVOTHYROXINE SODIUM 491 485 3 2
HYDROCHLOROTHIAZIDE 443 415 4 11
OMEPRAZOLE 438 378 5 5
LOSARTAN POTASSIUM 380 339 6 19
CARVEDILOL 358 277 7 27
POTASSIUM CHLORIDE 333 302 8 9
HYDROCODONE-ACETAMINOPHEN 323 293 S3 9 4
FUROSEMIDE 319 289 10 6
AMLODIPINE BESYLATE 269 252 11 7
WARFARIN SODIUM 263 255 12 10
METFORMIN HCL 254 196 13 8
ATORVASTATIN CALCIUM 250 220 14 15
PRAVASTATIN SODIUM 233 210 15 22
GABAPENTIN 198 144 16 12
ZOSTAVAX 194 183 17 201
CRESTOR 193 153 18 34
ATENOLOL 183 172 19 16
METOPROLOL TARTRATE 183 174 19 13
SERTRALINE HCL 183 162 19 21
METOPROLOL SUCCINATE 183 172 19 17
PANTOPRAZOLE SODIUM 172 112 23 37
DILTIAZEM 24HR CD 167 162 24 104
CITALOPRAM HBR 162 143 25 14
DONEPEZIL HCL 140 140 26 26
DIGOXIN 116 116 27 32
ALENDRONATE SODIUM 115 102 28 24
AMITRIPTYLINE HCL 106 56 R 29 52
PAROXETINE HCL 106 83 29 66
NAMENDA 98 98 31 31
POLYETHYLENE GLYCOL 3350 97 92 32 36
TRAZODONE HCL 95 58 33 48
ZOLPIDEM TARTRATE 91 77 34 20
GLYBURIDE 88 70 R 35 59
EVISTA 87 85 36 121
CYMBALTA 85 74 37 40
LOVASTATIN 84 83 38 38
SYNTHROID 84 84 38 50
FAMOTIDINE 83 69 40 61
GLIPIZIDE ER 78 78 41 135
OXYBUTYNIN CHLORIDE ER 78 63 41 125
FLUTICASONE PROPIONATE 73 54 43 35
FENOFIBRATE 69 37 44 77
GLIPIZIDE 69 61 44 69
ADVAIR DISKUS 67 46 46 60
CYCLOBENZAPRINE HCL 67 34 R 46 42
NEXIUM 67 48 46 30
ENALAPRIL MALEATE 64 55 49 55
DETROL LA 63 54 50 136
LANTUS 62 45 51 39
CLOPIDOGREL 62 50 51 44
CEPHALEXIN 61 61 53 75
ROPINIROLE HCL 59 43 54 72
GEMFIBROZIL 58 50 55 83
LOSARTAN-HYDROCHLOROTHIAZIDE 58 50 55 46
ALLOPURINOL 58 57 55 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 29 58 25
TAMSULOSIN HCL 56 56 59 28
MIRTAZAPINE 56 55 59 43
MELOXICAM 56 39 59 23
QUETIAPINE FUMARATE 56 56 59 70
TERAZOSIN HCL 54 54 63 112
LANSOPRAZOLE 54 43 63 155
ZETIA 53 42 65 81
CARBIDOPA-LEVODOPA 50 37 66 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.